This is a demo store. No orders will be fulfilled.

Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 20 Nov 2017  |  North America  |  Market Research

    Global Biologics Market—Companies-to-Action

    Biopharma Companies are Increasingly Collaborating with CDMOs, CROs, and Digital and Medical Equipment Companies for Biologics Discovery and Development

    This study on the "Global Biologics Market: Companies-to-Action" presents an overview of the global biologics landscape with an emphasis on the top 10 leading bio-pharma companies in the market. The study highlights the shifting focus and investments of bio-pharma companies towards biologics discovery and development, which is attributed to the gro...

    $3,000.00
  2. 27 Sep 2017  |  Africa  |  Market Research

    East African Pharmaceutical Market, Forecast to 2021

    Generic Pharmaceutical Products Continue to Dominate with Increased Foreign Direct Investment by Asian Manufacturers

    Pharmaceutical markets in Sub-Saharan Africa are experiencing rapid growth as governments and healthcare providers battle with their respective burdens of disease. The continent has one of the highest burdens of disease, such as HIV, malaria, and tuberculosis, yet has limited healthcare resources and spending. As such there are great opportunities ...

    $4,950.00
  3. 19 Apr 2017  |  Asia Pacific  |  Market Research

    Global CRO Market, Forecast to 2021

    The Global CRO Market to Reach $64.58 Billion by 2021

    The Global CRO Market, Forecast to 2021, presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides revenue forecasts for CROs globally by phase, therapeutic type and region. With the consolidation of the market as well as a higher cost and risk involved, the big companies are slowly shifting ...

    $4,950.00
  4. 02 Mar 2017  |  Global  |  Technology Research

    Biomarkers Enabling Diabetes and Obesity Management

    Novel Biomarker Research is Likely to Transform the Future of Obesity and Diabetes Management

    Obesity and diabetes are areas of growing concern across both, developed and developing countries. The rising geriatric population is likely to contribute to an increased prevalence of obesity and diabetes across the global landscape. Biomarker research is likely to facilitate the emergence of novel tools that may be useful for enhanced management ...

    $4,950.00
  5. 12 May 2015  |  Asia Pacific  |  Market Research

    Vital Signs - The Analyst's Perspective - April 2015 Issue

    The growing population base, driven by increased life expectancy and domestic investment, is expected to continuously accelerate GDP in Malaysia. Significant growth of healthcare expenditure is expected in the country to facilitate the improvement of medical access and provide companies with revenue-earning opportunities from 2015. Positive macroec...

    $450.00
  6. 02 Mar 2015  |  North America  |  Market Research

    Vital Signs - The Analyst's Perspective - February 2015 Issue

    This market insight provides an analysis of the regulatory trends occurring in the US life sciences market. Included in this deliverable is an analysis of the new molecular entities (NMEs) approved by the US Food and Drug Administration and predictions for 2014. Trends are showing that the Food and Drug Administration is moving towards greater ef...

    $500.00